PAD4 activity contributes to RA development, since PAD4-deficient mice have reduced autoantibodies and joint damage in arthritis models (70, 71), and a single nucleotide polymorphism of PAD4 is associated to an increased risk to develop RA in humans (72). The gene discussed is PADI4; the disease is rheumatoid arthritis.